Kewal Handa Led Salus Lifecare Offers Innovative & Strategic Management Approach to Indian Healthcare Sector!
The healthcare industry is transforming at a rapid pace. The introduction of new complex regulatory mandates is making the healthcare ecosystem unpredictable. To survive in this environment healthcare companies need professionals who have an in depth knowledge of the industry. Salus is a full service healthcare advisory firm that aims at becoming a catalyst in bringing about positive changes in the healthcare sector. We give our clients sound solutions, timely insight and strategic support to improve performance, recognize opportunity, execute transactions and manage governance. We look at the subtle difference between risk and opportunity and advice our clients to act suitably.
Strategic ADVISORY
Salus’ Strategic Advisory expertise helps healthcare organizations navigate their strategic roadmap by driving their agendas and advancing their mission. We clearly help define and balance our client’s strategic objectives, implement actions and measure results while mitigating risk.Mergers &
ACQUISITION
The Salus teams’ comprehensive knowledge of the healthcare industry facilitates in identifying leads of potential transactions. We work on the financial data, business proposals and legalities and also play the role of an arbitrator till the finalization of the agreement.
Business DEVELOPMENT
Salus’ Business development team consults business leaders and entrepreneurs on entry strategies and on business expansion. We share our know-how on how to strengthen and effectively grow our client’s businesses.
Business COLLABORATION
Salus’ Business Collaborations division works closely with Fund/P.E./Advisors firms for enterprise opportunities in various healthcare verticals.
Statutary ADVOCACY
Salus’ Statuary Advocacy team has a wealth of knowledge of the healthcare sector laws, regulations, cases and norms. We provide our clients with regulatory support, advocacy, insight and assistance to seize opportunity within the healthcare industry.
Management Team
Economic Times Kewal interview mar 14 2011pdf
Kewal Handa
Promoter Director
Kewal Handa has been as Managing Director of Pfizer Limited, India since 2005 to 2012. Prior to this, Kewal served as Executive Director – Finance, Pfizer Limited. Kewal was also the Managing Director of Wyeth Ltd.During his twenty years with the company, Kewal Handa has been entrusted with positions of increasing responsibility. He has a broad range of experience and has risen above his portfolio as Chief Financial Officer (CFO) by being a key contributor to shaping the future of Pfizer. He has demonstrated leadership and excellence in strategically guiding Pfizer Limited through three mergers with Parke Davis – Warner Lambert (India) Private Limited, Pharmacia and Wyeth Ltd. respectively. Kewal has radically changed the mindset and skill sets of colleagues across the organization to achieve these goals and help them capture market opportunities.
Ranga Iyer
Promoter Director
Ranga Iyer is currently an Advisor / Consultant to various Companies in the Pharma Industry in the areas of Mergers, Acquisitions, Business Strategy and Business Development. He is also an Advisor to Global Pharma Associations in the areas of Intellectual Property Rights / Regulatory matters and to India Health Progress on improving Access to healthcare. Ranga has concluded three M & A deals in pharmaceuticals till end 2012: Sale of manufacturing and marketing business of Biochem to Zydus Cadila Purchase of marketing & distribution of Nutraceutical brands of Universal Medicare by Sanofi Sale of manufacturing facility of UCB with continuity of supply for 5 years at negotiated prices
B. Sriram
Healthcare consultant
B.Sc. in Microbiology and Biochemistry
M.Sc in Biochemistry (University of Bombay)
Masters in Marketing Management from Jamnalal Bajaj Institute of Mgmt (Mumbai)
Have worked in leading pharmaceutical MNCs and Indian company in the areas of marketing, strategic planning, business development and operations. Worked two years in China. Have handled mature brands and also launched strategic molecules of companies in the cardiovascular, anti-infectives, oncology and vaccines segments, each of which gained leadership position in their respective fields.
Dr. Vishwas Sovani
Country Manager of Revogenex Inc
MD ( Pharmacology)
Diloma in Management IIM Ahmedabad
Dr Vishwas is currently the Country Manager of Revogenex Inc in India. He runs the local office and liaises with all the vendors to whom research work is outsourced. Vishwas has worked in Indian companies like Cipla and FDC, and multinationals like Wyeth(now Pfizer) and Organon(now Merck). He headed the medical function for 18 years, and was also a member of the management committee in Wyeth and Organon
Shenaz Z Khaleeli
Co-Founder and Technical Services Director PharmaLeaf India Private Limited
Shenaz Khaleeli is a highly qualified regulatory affair professional with a vast experience in clinical trials, development, manufacture and commercialization of NCE & generics supporting bio pharmaceutical, devices and life sciences companiesin a career spanning over 24 years.
CAPABILITIES IN INTERNATIONAL REGULATORY AFFAIRS
Indian Regulatory Affairs : Benefit/risk analysis, implementation of innovative regulatory strategies within Indian guidelines for speedy and efficient approvals in comparison with Industry norms
Address for Correspondence
BREAKFASTNEWS 